BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35457185)

  • 1. Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma.
    Lee YC; Lin CH; Chang WL; Lin WD; Pan JK; Wang WJ; Su BC; Chung HH; Tsai CH; Lin FC; Wang WC; Lu PJ
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
    Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
    Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
    Liu B; Li X; Li C; Xu R; Sun X
    Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes.
    Kuo IY; Huang YL; Lin CY; Lin CH; Chang WL; Lai WW; Wang YC
    J Biomed Sci; 2019 Feb; 26(1):20. PubMed ID: 30777052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma.
    Lin CH; Tsai CH; Yeh CT; Liang JL; Hung WC; Lin FC; Chang WL; Li HY; Yao YC; Hsu TI; Lee YC; Wang YC; Sheu BS; Lai WW; Calkins MJ; Hsiao M; Lu PJ
    Oncotarget; 2016 Jun; 7(26):39680-39693. PubMed ID: 27203740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
    Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
    Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MicroRNA-133b suppresses cell proliferation and invasion of esophageal squamous cell carcinoma via downregulating TAGLN2 expression].
    Tang Y; Liu JH; Shi ZX; Li Z; Liu HT; Lu P
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):91-96. PubMed ID: 30862136
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.
    Hsieh CH; Kuan WH; Chang WL; Kuo IY; Liu H; Shieh DB; Liu H; Tan B; Wang YC
    J Biomed Sci; 2022 Oct; 29(1):90. PubMed ID: 36310172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of miR-429 on cell migration and invasion by targeting Slug in esophageal squamous cell carcinoma.
    Zong M; Liu Y; Zhang K; J Y; Chen L
    Pathol Res Pract; 2019 Sep; 215(9):152526. PubMed ID: 31324391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
    Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells.
    Matsushima K; Isomoto H; Yamaguchi N; Inoue N; Machida H; Nakayama T; Hayashi T; Kunizaki M; Hidaka S; Nagayasu T; Nakashima M; Ujifuku K; Mitsutake N; Ohtsuru A; Yamashita S; Korpal M; Kang Y; Gregory PA; Goodall GJ; Kohno S; Nakao K
    J Transl Med; 2011 Mar; 9():30. PubMed ID: 21426561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma.
    Park S; Joung JG; Min YW; Nam JY; Ryu D; Oh D; Park WY; Lee SH; Choi Y; Ahn JS; Ahn MJ; Park K; Sun JM
    J Immunother Cancer; 2019 May; 7(1):128. PubMed ID: 31097034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
    Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells.
    Manavalan TT; Teng Y; Litchfield LM; Muluhngwi P; Al-Rayyan N; Klinge CM
    PLoS One; 2013; 8(4):e62334. PubMed ID: 23626803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma.
    Ma T; Zhao Y; Lu Q; Lu Y; Liu Z; Xue T; Shao Y
    Biomed Pharmacother; 2018 Feb; 98():680-686. PubMed ID: 29304493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.
    Song Y; Li J; Zhu Y; Dai Y; Zeng T; Liu L; Li J; Wang H; Qin Y; Zeng M; Guan XY; Li Y
    Oncotarget; 2014 Nov; 5(22):11669-80. PubMed ID: 25375090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
    Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
    Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
    Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
    Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.